[{"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0694-2020", "product_description": "BUP 20MG/SUF 105MCG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12122019@8 Exp. 12/21/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84990", "recalling_firm": "American Health Packaging", "address_1": "2550 John Glenn Ave Ste A", "address_2": "", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0849-2020", "product_description": "Desmopressin Acetate Tablets, 0.2 mg, 30 tablets (3 x 10 unit dose blister cards), Rx Only, Packaged and distributed by:  American Health Packaging, Columbus, Ohio 43217.  NDC Carton: 68084-604-21; NDC Unit Dose 68084-604-11", "product_quantity": "3,720 cartons", "reason_for_recall": "GMP Deviations: Product bottle may be absent of desiccant.", "recall_initiation_date": "20200207", "center_classification_date": "20200218", "termination_date": "20220804", "report_date": "20200226", "code_info": "Lot 180510, exp 3/31/2020; Lot 181912, exp 4/30/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84798", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0830-2020", "product_description": "Desmopressin Acetate Tablets, 0.1 mg, 100-count bottle, Rx Only, Manufactured by: Actavis Laboratories, Inc. Fort Lauderdale, FL 33314 USA, Distributed by: Actavis Pharma, Inc. Parisppany, NJ 07054 USA, NDC 0591-2464-01", "product_quantity": "22,868 bottles", "reason_for_recall": "GMP Deviations: Product bottle may be absent of desiccant.", "recall_initiation_date": "20200127", "center_classification_date": "20200206", "termination_date": "20201210", "report_date": "20200212", "code_info": "Lot #: 1281203M, exp. date 03/2020 and 1290113M, exp. date 04/2020"}, {"status": "Terminated", "city": "Waltham", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85228", "recalling_firm": "Fresenius Medical Care Holdings, Inc.", "address_1": "920 Winter St Bld 950", "address_2": "", "postal_code": "02451-1521", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed throughout the United States.", "recall_number": "D-1064-2020", "product_description": "Sodium Chloride 0.9% Injection, USP, 1000 mL bags, Rx only, Manufactured by: Fresenius Medical Care North America, Waltham, MA 02451", "product_quantity": "32,592 bags", "reason_for_recall": "CGMP Deviation: Chemical indicators were not positioned properly during sterilization process.", "recall_initiation_date": "20200305", "center_classification_date": "20200326", "termination_date": "20230203", "report_date": "20200325", "code_info": "Lot #: 19EG02012, 19EG02019, Exp. Date 05/2020; 19DG02050, Exp. Date 04/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0775-2020", "product_description": "TRIMIX -A  (UA) 30MG/1MG/5 MCG/ML INJ in 1 mL vial  Assurance Infusion (713) 533-8800", "product_quantity": "10 vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 07082019@31 Exp. 01/04/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0668-2020", "product_description": "BAC 200MCG/BUP22MG/CLON210MCG/HYDROM 15MG/SUF800MCG/ML ML INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12172019@3 Exp. 12/26/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0699-2020", "product_description": "BUP 30MG/ FENT 400MCG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12132019@3 Exp. 12/22/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0759-2020", "product_description": "MORPHINE 5MG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "2 syringes", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lots: 12122019@7 Exp. 12/21/2019; 12162019@27 Exp. 12/25/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0714-2020", "product_description": "BUP 5MG/MORP 10MG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lots: 12122019@21 Exp. 12/21/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0949-2020", "product_description": "Cyanocobalamin/Folinic Acid Injection, CYANOCOBALAMIN : FOLINIC ACID 2000 MCG/ML: 500MCG/ML INJECTABLE, For IV, IM, SC Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0333-3", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 09252019+52967, Exp 4/4/2020"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0762-2020", "product_description": "PHENOL 2.5% STERILE  SOLUTION in 50 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "2 syringes", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 10142019@14 Exp. 01/12/2020; 11042019@8 Exp. 02/02/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Santa Ana", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84618", "recalling_firm": "McGuff Compounding Pharmacy Services, Inc.", "address_1": "2921 W Macarthur Blvd Ste 142", "address_2": "", "postal_code": "92704-7944", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Distributed Nationwide in the US", "recall_number": "D-0802-2020", "product_description": "Lipoic Acid Injection (aka Alpha Lipoic Acid or Thioctic Acid), 1,200 mg/30 mL (40 mg/mL) Sterile 30 mL Multiple Dose Vial, Rx Only, McGuff Compounding Pharmacy Services, Inc., Santa Ana, CA 92704", "product_quantity": "146 30 ml vials were dispensed", "reason_for_recall": "Presence of Particulate Matter: filmy/cloudy particulate observed in vial.", "recall_initiation_date": "20190110", "center_classification_date": "20200129", "termination_date": "20231120", "report_date": "20200122", "code_info": "Lot #: 18M0991, Preparation #: 390-2678, Beyond Usage Date: 06/15/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0757-2020", "product_description": "MORPHINE 30MG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "2 syringes", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lots: 12132019@6 Exp. 12/22/2019; 12182019@5 Exp. 12/27/2019", "more_code_info": ""}, {"status": "Terminated", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA091569"], "brand_name": ["AMOXICILLIN AND CLAVULANATE POTASSIUM"], "generic_name": ["AMOXICILLIN AND CLAVULANATE POTASSIUM"], "manufacturer_name": ["Aurobindo Pharma Limited"], "product_ndc": ["65862-501", "65862-502", "65862-503"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMOXICILLIN", "CLAVULANATE POTASSIUM"], "rxcui": ["562251", "562508", "617296"], "spl_id": ["2b91e9f8-c77e-4330-8fc1-e574758f0db6"], "spl_set_id": ["ffb158a1-83ba-4100-9221-175aa986dc3e"], "package_ndc": ["65862-501-30", "65862-501-05", "65862-502-20", "65862-502-05", "65862-503-20", "65862-503-01"], "is_original_packager": [true], "unii": ["Q42OMW3AT8", "804826J2HU"]}, "product_type": "Drugs", "event_id": "84910", "recalling_firm": "AuroMedics Pharma LLC", "address_1": "279 Princeton Hightstown Rd", "address_2": "", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0852-2020", "product_description": "Amoxicillin and Clavulanate Potassium Tablets, USP, 875 mg/125 mg, 20-count bottles, Distributed by: Aurobindo Pharma USA. Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520 Made in India; NDC 65862-503-20", "product_quantity": "30432 bottles", "reason_for_recall": "Presence of Foreign Substance: Customer complaint of a foreign substance identified as nylon cable tie", "recall_initiation_date": "20200207", "center_classification_date": "20200219", "termination_date": "20221117", "report_date": "20200219", "code_info": "Lot #: SM8719040-A, Exp. Date 02/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0689-2020", "product_description": "BUP 2.5MG/ CLONI 5MCG/ FENT 200MCG/ SUF 50MCG/ML (40)  INJ in 20 mL syringe Assurance Infusion (713) 533-8800", "product_quantity": "2 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12122019@4 Exp. 12/21/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0687-2020", "product_description": "BUP 17MG/MORP 22MG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12122019@25 Exp. 12/21/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0696-2020", "product_description": "BUP 23MG/HYDROM 25MG/SUF 100MCG/ML  INJ in 20 mL syringe Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12162019@15 Exp. 12/25/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Cranbury", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA065053"], "brand_name": ["DOXYCYCLINE"], "generic_name": ["DOXYCYCLINE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["63304-614", "63304-615", "63304-616"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DOXYCYCLINE"], "rxcui": ["700408", "1649401", "1649990"], "spl_id": ["338488d1-e9d8-6b00-e063-6294a90a37c0"], "spl_set_id": ["829dbd3d-5c2b-47b8-96a5-423af78c93b9"], "package_ndc": ["63304-614-20", "63304-614-05", "63304-614-01", "63304-614-13", "63304-615-05", "63304-615-11", "63304-615-01", "63304-616-20", "63304-616-05", "63304-616-01", "63304-616-13", "63304-616-50"], "is_original_packager": [true], "upc": ["0363304614015"], "nui": ["N0000175882", "N0000007948"], "pharm_class_epc": ["Tetracycline-class Drug [EPC]"], "pharm_class_cs": ["Tetracyclines [Chemical/Ingredient]"], "unii": ["N12000U13O"]}, "product_type": "Drugs", "event_id": "85230", "recalling_firm": "Sun Pharmaceutical Industries, Inc.", "address_1": "270 Prospect Plains Rd", "address_2": "", "postal_code": "08512-3605", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1032-2020", "product_description": "Doxycycline Capsules, USP, 75 mg, 100-count bottle, Rx only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901; Distributed by Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; NDC 63304-615-01.", "product_quantity": "624 bottles", "reason_for_recall": "CGMP Deviations: Doxycycline capsules were not manufactured under Current Good Manufacturing Practice conditions.", "recall_initiation_date": "20200313", "center_classification_date": "20200318", "termination_date": "20210209", "report_date": "20200325", "code_info": "Lot #: AA39490, Exp 03/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0745-2020", "product_description": "HYDROMORPHONE 4MG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12182019@6 Exp. 12/27/2019", "more_code_info": ""}, {"country": "United States", "city": "Allegan", "address_1": "515 Eastern Ave", "reason_for_recall": "CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.", "address_2": "", "product_quantity": "", "code_info": "Lots:  8FE1455,   8GE1343,   8HE1225,   8KE2834,   8KE2249,   8ME2730,   9AE2838,   9EE2639,   9FE2993", "center_classification_date": "20200313", "distribution_pattern": "Nationwide USA", "state": "MI", "product_description": "Regular Strength Acid Reducer, Ranitidine tablets, USP 75 mg, 160 tablets per bottle. [NDC: Brand] NDC CVS Health.: 69842-293-06", "report_date": "20200325", "classification": "Class II", "openfda": {}, "recalling_firm": "Perrigo Company PLC", "recall_number": "D-1016-2020", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "84127", "termination_date": "20201106", "more_code_info": "", "recall_initiation_date": "20191023", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0721-2020", "product_description": "CLON 100MCG/MORP 12MG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12122019@24 Exp. 12/21/2019", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84516", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Natiowide", "recall_number": "D-0639-2020", "product_description": "Glenmark Ranitidine Tablets USP 150 mg Rx Only 60 Tablets Manufactured by: Glenmark Pharmaceuticals Ltd. Colvale-Bandez, Goa 403513, India Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ   NDC 68462-248-60", "product_quantity": "208,668 bottles", "reason_for_recall": "CGMP Deviations: Presence of NDMA impurity detected in product.", "recall_initiation_date": "20191217", "center_classification_date": "20200105", "report_date": "20200115", "code_info": "7701164A  7701471A  7701670B  7701827A  7702242A  7702705A  7702947A  7703408A  7704494A  7704495A  19190289  19190342  19190372  7702737A"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0707-2020", "product_description": "BUP 40MG/FENT 1200MCG/SUF 400MCG/ML  INJ in 20 mL syringe Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lots: 12102019@4 Exp. 12/19/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0684-2020", "product_description": "BUP 15MG/CLON 400MCG/ FENT 6000MCG/ML INJ in 20 mL syringe Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12132019@5 Exp. 12/22/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "85018", "recalling_firm": "Akorn, Inc.", "address_1": "1925 W Field Ct Ste 300", "address_2": "N/A", "postal_code": "60045-4862", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within United States and Puerto Rico", "recall_number": "D-0860-2020", "product_description": "Well at Walgreens Sodium Chloride Ophthalmic Ointment USP, 5%, 3.5 g tubes, Distributed by: Walgreen Co. 200 Wilmot Rd., Deerfield, IL 60015. NDC 0363-9050-00.", "product_quantity": "24 tubes", "reason_for_recall": "Presence of Particulate Matter: Brown spots observed on the inside of the tube of product, identified as tin with trace copper, which are the base of the materials of construction for the tube.", "recall_initiation_date": "20200221", "center_classification_date": "20200227", "termination_date": "20220728", "report_date": "20200304", "code_info": "Lot #:8G59A, Exp. Date 06/2021"}, {"country": "United States", "city": "Decatur", "address_1": "1316 Commerce Dr", "reason_for_recall": "Subpotent", "address_2": "", "product_quantity": "a) 597 jars; b) 411 jars; c) 5 jars; d) 1004 jars: e) 76 jars; f) 1592 jars", "code_info": "Lots: a) 1804030048 Exp. 06/06/2020; 1712270019, 1802160017 Exp. 08/06/2020; 1804300021, 1806270007, 1808090056, 1904290047 Exp. 04/16/2021; 1810190004, 1812200072, 1901250024 Exp. 08/13/2021;   1902190028, 1907260018 Exp 09/14/2021;     b) 1804030049 Exp. 06/06/2020; 1712270020, 1802160018 Exp. 08/06/2020;   1804300022, 1806270008, 1808090057, 1904290048 Exp. 04/16/2021; 1810190005, 1812200073, 1901250025 Exp. 08/13/2021; 1902190029, 1907260019 Exp. 09/14/2021;     c) 1802160022 Exp. 08/06/2020; 1810190009, 1812200077 Exp. 08/13/2021; 1907260023 Exp. 09/14/2021;     d) 1804030050 Exp 06/06/2020; 1712270021, 1802160019 Exp. 08/06/2020;  1804300023, 1806270009, 1808090058, 1904290049 Exp 04/16/2021; 1810190006, 1812200074, 1901250026 Exp. 08/13/2021; 1902190030, 1907260020 Exp. 09/14/2021;     e) 1802160021 Exp. 08/06/2020; 1804300025, 1806270011, 1808090060 Exp. 04/16/2021; 1810190008 Exp. 08/13/2021; 1812200076 Exp. 08/13/2021; 1901250028 Exp. 08/13/2021; 1902190031 Exp. 09/14/2021; 1907260022 Exp. 09/14/2021; f) 1712270022 Exp. 08/06/2020; 1802160020 Exp. 08/06/2020; 1804030051 Exp. 06/06/2020; 1804300024 Exp. 04/16/2021; 1806270010 Exp. 04/16/2021; 1808090059 Exp. 04/16/2021; 1810190007 Exp. 08/13/2021; 1812200075 Exp. 08/13/2021; 1901250027 Exp. 08/13/2021; 1904290050 Exp. 04/16/2021; 1907260021 Exp. 09/14/2021", "center_classification_date": "20200115", "distribution_pattern": "United States, Australia, Canada, Israel, Philippines, Taiwan.", "state": "AL", "product_description": "Estriol USP Micronized a) 100 gm NDC 62991-2159-04; b) 1 gm NDC 62991-2159-01; c) 1 kg NDC 62991-2159-06; d) 25 gm NDC 62991-2159-03; e) 500 gm NDC 62991-2159-05; f) 5 gm NDC 62991-2159-02, Rx Only Repackaged by: Letco Medical, LLC. Decatur, AL 35601", "report_date": "20200122", "classification": "Class II", "openfda": {}, "recalling_firm": "Letco Medical LLC", "recall_number": "D-0780-2020", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "84686", "termination_date": "20210407", "more_code_info": "", "recall_initiation_date": "20200110", "postal_code": "35601-7539", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0693-2020", "product_description": "BUP 20MG/SUF 1000MCG/ML  INJ in 20 mL syringe Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12172019@10 Exp. 12/26/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Claremont", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "84279", "recalling_firm": "Natures Rx", "address_1": "310 N Indian Hill Blvd", "address_2": "Ste 600", "postal_code": "91711-4611", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-0633-2020", "product_description": "Silver Bullet, Get Bigger and Harder, Works in Minutes, Lasts for Days, 10 male enhancement capsules in blister foil package, 725mg per capsule, Distributed by Silver Bullet Ltd, Golden Springs, CO, USA, UPC: 610877392698.", "product_quantity": "2,800 capsules", "reason_for_recall": "Marketed Without an Approved NDA/ANDA; Product contains undeclared active ingredient - Sildenafil.", "recall_initiation_date": "20191113", "center_classification_date": "20191231", "termination_date": "20230208", "report_date": "20200108", "code_info": "Lot  # 01251ZX1, exp. date 11/2022  UPC: 610877392698"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "85018", "recalling_firm": "Akorn, Inc.", "address_1": "1925 W Field Ct Ste 300", "address_2": "N/A", "postal_code": "60045-4862", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within United States and Puerto Rico", "recall_number": "D-0861-2020", "product_description": "CVS Health Sodium Chloride Ophthalmic Ointment USP, 5%, 3.5 g tubes, Distributed By: CVS Pharmacy Inc. One CVS Drive, Woonsocket, RI 02895, NDC 59779-303-01", "product_quantity": "N/A", "reason_for_recall": "Presence of Particulate Matter: Brown spots observed on the inside of the tube of product, identified as tin with trace copper, which are the base of the materials of construction for the tube.", "recall_initiation_date": "20200221", "center_classification_date": "20200227", "termination_date": "20220728", "report_date": "20200304", "code_info": "Lot #:8G50A, Exp. Date 06/2021"}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0939-2020", "product_description": "AscorbiX (Buffered C) Injection, Ascorbix (30ML) 500MG/ML Injectable, For IV, IM, SC Use, Refrigerate, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0226-3", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 07112019+52635, Exp 1/17/2020; 09092019+52890, Exp 3/17/2020"}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0951-2020", "product_description": "Dexamethasone (LA) Injectable Suspension, DEXAMETHASONE LA [10ML] 16MG  INJ SUSP, For IM, IA Use, Shake Well, 10 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0630-1", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 10022019+53002, Exp 10/1/2020"}, {"status": "Terminated", "city": "Livonia", "state": "MI", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA204203"], "brand_name": ["QUETIAPINE FUMARATE"], "generic_name": ["QUETIAPINE FUMARATE"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-6801", "0904-6802", "0904-6803", "0904-6804", "0904-6805"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["QUETIAPINE FUMARATE"], "spl_id": ["cdab9d60-c12c-474b-aa71-b7916dab8e7c"], "spl_set_id": ["b02324b1-e7f0-4cbc-8778-5f7c4a5d194a"], "package_ndc": ["0904-6801-61", "0904-6802-61", "0904-6803-61", "0904-6804-61", "0904-6805-61"], "original_packager_product_ndc": ["68180-612", "68180-613", "68180-614", "68180-615", "68180-616"], "unii": ["2S3PL1B6UJ"]}, "product_type": "Drugs", "event_id": "85138", "recalling_firm": "The Harvard Drug Group", "address_1": "17177 N Laurel Park Dr Ste 233", "address_2": "", "postal_code": "48152-3951", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1000-2020", "product_description": "Quetiapine Fumarate Extended-Release Tablets, 150 mg, 100 tablets per unit dose carton, Rx only, Manufactured by: Lupin Limited, Pithampur (M.P.) 454775 India; Distributed by: Major Pharmaceuticals, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI 48152 USA.  NDC: 0904-6802-61", "product_quantity": "1 carton", "reason_for_recall": "Labeling; Incorrect or Missing Package Insert: Product was packaged with the package insert for Quetiapine Fumarate Tablets not Quetiapine Fumarate Extended-Release Tablets.", "recall_initiation_date": "20200227", "center_classification_date": "20200311", "termination_date": "20220924", "report_date": "20200318", "code_info": "Lot, expiry: Lot N00036, exp 05/2021", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84516", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Natiowide", "recall_number": "D-0644-2020", "product_description": "Glenmark Ranitidine Tablets USP 150 mg Rx Only 500 Tablets Manufactured by: Glenmark Pharmaceuticals Ltd. Colvale-Bandez, Goa 403513, India   Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ   NDC 68462-248-05", "product_quantity": "1,712,632 bottles", "reason_for_recall": "CGMP Deviations: Presence of NDMA impurity detected in product.", "recall_initiation_date": "20191217", "center_classification_date": "20200105", "report_date": "20200115", "code_info": "7701034A  7701057A  7701058A  7701059A  7701060A  7701061A  7701071A  7701072A  7701073A  7701074A  7701105A  7701106A  7701107A  7701108A  7701109A  7701113A  7701114A  7701115A  7701116A  7701121A  7701122A  7701123A  7701124A  7701125A  7701126A  7701151A  7701152A  7701165A  7701154A  7701155A  7701163A  7701176A  7701190A  7701221A  7701222A  7701223A  7701224A  7701225A  7701235A  7701253A  7701254A  7701255A  7701256A  7701257A  7701258A  7701259A  7701266A  7701267A  7701268A  7701273A  7701275A  7701276A  7701277A  7701294A  7701295A  7701296A  7701297A  7701300A  7701301A  7701302A  7701303A  7701304A  7701306A  7701307A  7701308A  7701309A  7701310A  7701311A  7701312A  7701313A  7701314A  7701315A  7701316A  7701328A  7701329A  7701330A  7701331A  7701332A  7701333A  7701344A  7701153A  7701175A  7701234A  7701274A  7701305A  7701345A  7701352A  7701353A  7701354A  7701355A  7701356A  7701382A  7701383A  7701384A  7701385A  7701402A  7701403A  7701404A  7701405A  7701419A  7701420A  7701422A  7701423A  7701424A  7701425A  7701426A  7701427A  7701430A  7701432A  7701433A  7701448A  7701449A  7701450A  7701451A  7701454A  7701455A  7701471B  7701557A  7701558A  7701559A  7701583A  7701584A  7701585A  7701586A  7701587A  7701588A  7701614A  7701615A  7701616A  7701621A  7701637A  7701638A  7701639A  7701652A  7701653A  7701654A  7701655A  7701656A  7701657A  7701658A  7701664A  7701665A  7701666A  7701667A  7701668A  7701669A  7701670A  7701680A  7701613A  7701699A  7701700A  7701701A  7701714A  7701715A  7701716A  7701717A  7701718A  7701719A  7701720A  7701721A  7701781A  7701782A  7701783A  7701784A  7701796A  7701926A  7701927A  7701937A  7701938A  7701939A  7701940A  7701941A  7702004A  7702005A  7702006A  7702007A  7702008A  7702009A  7702010A  7702011A  7702013A  7702014A  7702068A  7702222A  7702223A  7702224A  7702230A  7702231A  7702232A  7702233A  7702242B  7702243A  7702244A  7702245A  7702246A  7702247A  7702248A  7702249A  7702250A  7702251A  7702252A  7702291A  7702292A  7702293A  7702302A  7702303A  7702304A  7702305A  7702306A  7702307A  7702308A  7702309A  7702331A  7702332A  7702333A  7702334A  7702339A  7702340A  7702346A  7702353A  7702354A  7702355A  7702356A  7702376A  7702377A  7702378A  7702379A  7702390A  7702310A  7702411A  7702412A  7702490A  7702493A  7702494A  7702498A  7702499A  7702500A  7702501A  7702502A  7702503A  7702516A  7702517A  7702518A  7702519A  7702549A  7702550A  7702551A  7702552A  7702601A  7702602A  7702603A  7702604A  7702605A  7702606A  7702607A  7702608A  7702621A  7702622A  7702623A  7702655A  7702656A  7702657A  7702658A  7702741A  7702742A  7702743A  7702765A  7702766A  7702777A  7702778A  7702779A  7702780A  7702781A  7702782A  7702783A  7702784A  7702794A  7702795A  7702796A  7702797A  7702811A  7702812A  7702813A  7702814A  7702815A  7702816A  7702817A  7702818A  7702819A  7702820A  7702821A  7702822A  7702848A  7702849A  7702850A  7702856A  7702857A  7702861A  7702896A  7702897A  7702898A  7702899A  7702910A  7702911A  7702912A  7702913A  7702914A  7702915A  7702916A  7702924A  7702925A  7702926A  7702927A  7703060A  7703061A  7703062A  7703063A  7703064A  7703065A  7703066A  7703067A  7703068A  7703144A  7703145A  7703146A  7703147A  7703174A  7703175A  7703176A  7703177A  7703178A  7703179A  7703180A  7703181A  7703182A  7703183A  7703191A  7703192A  7703193A  7703194A  7703195A  7703236A  7703237A  7703238A  7703239A  7703240A  7703248A  7703249A  7703250A  7703251A  7703252A  7703253A  7703254A  7703255A  7703283A  7703284A  7703290A  7703291A  7703292A  7703293A  7703294A  7703295A  7703296A  7703318A  7703330A  7703331A  7703332A  7703333A  7703334A  7703347A  7703348A  7703349A  7703350A  7703351A  7703394A  7703395A  7703409A  7703491A  7703492A  7703493A  7703494A  7703495A  7703496A  7703497A  7703498A  7703499A  7703500A  7703501A  7703502A  7703503A  7703504A  7703635A  7703636A  7703637A  7703638A  7703775A  7703776A  7703777A  7703778A  7703779A  7703780A  7703781A  7703782A  7703783A  7703925A  7703926A  7703934A  7703935A  7703936A  7703937A  7703938A  7703939A  7703970A  7703971A  7703972A  7704003A  7704004A  7704098A  7704099A  7704100A  7704101A  7704102A  7704103A  7704104A  7704181A  7704182A  7704183A  7704184A  7704185A  7704186A  7704187A  7704188A  7704189A  7704190A  7704191A  7704192A  7704193A  7704297A  7704298A  7704299A  7704300A  7704301A  7704302A  7704327A  7704328A  7704329A  7704330A  7704331A  7704332A  7704333A  7704334A  7704408A  7704409A  7704410A  7704411A  7704412A  7704413A  7704419A  7704420A  7704421A  7704422A  7704423A  7704424A  7704425A  7704496A  7704497A  7704502A  7704503A  7704504A  7704505A  7704506A  7704507A  7704559A  7704560A  7704561A  7704562A  7704574A  7704575A  7704606A  7704607A  7704608A  7704649A  7704650A  7704651A  7704652A  7704653A  7704654A  7704655A  7704656A  7704657A  7704658A  7704659A  7704673A  7704674A  7704675A  7704676A  7704677A  7704678A  7704679A  7704735A  7704736A  7704737A  7704738A  7704739A  7704810A  7704811A  7704812A  7704834A  7704835A  7704836A  7704837A  7704856A  7704857A  7704948A  7704949A  7704950A  7704951A  7704971A  7704972A  7704973A  7704974A  7704975A  7704976A  7704977A  7704980A  7704981A  7704982A  7704983A  7704984A  7704985A  7705014A  7705049A  7705125A  7705126A  7705127A  7705128A  7705129A  7705130A  7705131A  7705132A  7705133A  7705134A  7705135A  7705136A  7705137A  7705138A  7705150A  7705151A  7705152A  7705153A  7705382A  7705383A  7705386A  7705388A  7705391A  7705566A  7705568A  7705569A  7705589A  7705591A  7705595A  7705596A  7705597A  7705598A  7705599A  7705600A  7705601A  7705614A  7705615A  7705618A  7705619A  7705620A  7705621A  7705622A  7705623A  7705624A  7705387A  7705389A  7705390A  7705592A  7705593A  7705594A  7705602A  7705616A  7705617A  19190289  19190342  19190372  19190385  19191898  19192447  19192461  19192468  19192481  7702624A  7702625A  7702738A  7702739A  7702740A  7704858A  7704859A  7704860A  7704861A  7704892A  7704893A  7704894A  7704895A  7704896A  7704912A  7704926A  7704927A  7704928A  7704929A  7704930A  7704931A  7704932A"}, {"status": "Terminated", "city": "Hastings", "state": "NE", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85081", "recalling_firm": "Redline Pharmacy Solutions", "address_1": "2415 Osborne Dr E Ste 100", "address_2": "", "postal_code": "68901-1999", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Sold to patients in Nebraska", "recall_number": "D-1011-2020", "product_description": "Morphine Sulfate (MITIGO), 5 mg/mL intrathecal, 40 mL per syringe. Redline Specialty Pharmacy, 2415 Osborne Drive E, #100 Hastings, NE 68901", "product_quantity": "1 40 ml syringe", "reason_for_recall": "Lack Of Processing Controls", "recall_initiation_date": "20200224", "center_classification_date": "20200312", "termination_date": "20220331", "report_date": "20200318", "code_info": "Lot 02242020@14", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0692-2020", "product_description": "BUP 20MG/CLON 300MCG/FENT 2000MCG/ML  INJ in 20 mL syringe Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12122019@28 Exp. 12/21/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Cherry Hill", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA075772"], "brand_name": ["KETOROLAC TROMETHAMINE"], "generic_name": ["KETOROLAC TROMETHAMINE"], "manufacturer_name": ["Hikma Pharmaceuticals USA Inc."], "product_ndc": ["0641-6041", "0641-6043", "0641-6042"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["KETOROLAC TROMETHAMINE"], "rxcui": ["860092", "1665459", "1665461"], "spl_id": ["25d6c438-45d2-4162-91c2-b5caa0f86bf3"], "spl_set_id": ["0c2c75c9-ed7b-46a8-9543-429bf2d8f090"], "package_ndc": ["0641-6043-01", "0641-6043-25", "0641-6042-01", "0641-6042-25", "0641-6041-01", "0641-6041-25"], "is_original_packager": [true], "unii": ["4EVE5946BQ"]}, "product_type": "Drugs", "event_id": "84534", "recalling_firm": "Hikma Pharmaceuticals USA Inc.", "address_1": "2 Esterbrook Ln", "address_2": "", "postal_code": "08003-4002", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0658-2020", "product_description": "Ketorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL), packaged in 2 mL Single Dose Vials (NDC 0641-6043-01), 25 vials/shelf-pack (NDC 0641-6043-25), For IM Use Only, Rx only, Manufactured by: WEST-WARD Eatontown, NJ 07724 USA.", "product_quantity": "25,817 shelf packs/25 vials per pack", "reason_for_recall": "Presence of Particulate Matter: particles identified as polydimethylsiloxane (PDMS)", "recall_initiation_date": "20191217", "center_classification_date": "20200302", "termination_date": "20210609", "report_date": "20200122", "code_info": "038368,  Exp. Mar 2020; 058314, Exp. May 2020; 078305,  078307, Exp. July 2020; 118362 Exp. Nov 2020", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0677-2020", "product_description": "Bi-Mix 30 mg/1 mg/mL Inj. in 1 mL vials Assurance Infusion (713) 533-8800", "product_quantity": "15 vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lots: 09192019@19 Exp. 03/17/2020; 08162019@5 Exp. 02/12/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0697-2020", "product_description": "BUP 2MG/ HYDROM 2MG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12162019@10 Exp. 12/25/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0723-2020", "product_description": "CLON 500MCG/HYDROM 5MG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12162019@22 Exp. 12/25/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0933-2020", "product_description": "Alprostadil/Papaverine Hydrochloride/Phentolamine Mesylate/Atropine Sulfate Injection, 40 mcg/25 mg/0.5mg/0.01mg/ml, For Intracavernosal Use, Freeze, 2.5 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0549-2", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 12042019+533225, Exp 1/17/2020"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0698-2020", "product_description": "BUP 3.5MG/ HYDROM 4MG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12122019@27 Exp. 12/21/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0663-2020", "product_description": "Autologous Serum 20% Eye Drops in 3 mL droppers Assurance Infusion (713) 533-8800", "product_quantity": "32 droppers", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lots: 12092019@33 Exp. 03/08/2020; 11112019@30 Exp. 02/09/2020; 10012019@17 Exp. 12/30/2019; 10162019@18 Exp. 01/14/2020; 10252019@11 Exp. 01/23/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0948-2020", "product_description": "Cyanocobalamin Injection, CYANOCOBALAMIN   2000 MCG/ML INJECTABLE, For IV, IM, SC Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0330-3", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #:07172019+52695, 07172019+52697, 07252019+52759, Exp 1/25/2020"}, {"status": "Terminated", "city": "El Paso", "state": "TX", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "84620", "recalling_firm": "Idelle Labs", "address_1": "One Helen Of Troy Plaza", "address_2": "N/A", "postal_code": "79912", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0785-2020", "product_description": "SURE 48hr Confidence Regular Original Solid Anti-Perspirant & Deodorant Net Wt 2.7 oz (76g) NDC# 41595-5514-1 UPC 8 83484 717936 6 Made in Canada and Distributed by Idelle Labs, Ltd., El Paso, TX 79912", "product_quantity": "Unknown", "reason_for_recall": "Labeling Product Contains Undeclared API: Active Ingredient on label is not the active ingredient in the product.", "recall_initiation_date": "20191120", "center_classification_date": "20200116", "termination_date": "20220928", "report_date": "20200115", "code_info": "Lots: 19279K1, 19279K2, 19280K1"}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0961-2020", "product_description": "Levocarnitine Injection, LEVOCARNITINE  500 MG/ML INJECTABLE, For IV Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-9260-3", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 08212019+52824, Exp 2/17/2020"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0722-2020", "product_description": "CLON 300MCG/MORP 10MG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12132019@8 Exp. 12/22/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Indiana", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83645", "recalling_firm": "RemedyRepack Inc.", "address_1": "625 Kolter Dr Ste 4", "address_2": "", "postal_code": "15701-3571", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "PA", "recall_number": "D-1030-2020", "product_description": "Lisinopril/HCTZ 20mg/12.5mg Tablet, QTY: 30 tablets per blister card, MFG: Lupin Pharma Baltimore, MD 21202, NDC 68180-0519-02 (Original NDC of 500 count bottle); 70518-0382-03 (Repackaged NDC for blister cards).", "product_quantity": "480 tablets", "reason_for_recall": "Presence of Foreign Tablets/Capsules: This is a spin-off recall of D-1581-2019 due to a product complaint where one of Lupin's Fenofibrate 145mg was observed in the 500 s count product bottle.", "recall_initiation_date": "20190805", "center_classification_date": "20200316", "termination_date": "20230602", "report_date": "20200325", "code_info": "Lot #: J0322819-091418, Exp: 09/30/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Hauppauge", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84857", "recalling_firm": "Contract Pharmacal Corporation", "address_1": "135 Adams Ave", "address_2": "", "postal_code": "11788-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0857-2020", "product_description": "Leader Extra Strength Acetaminophen Tablets, 500 mg Pain Reliever/Fever Reducer,100-count bottles,Distributed by Cardinal Health, Dublin OHIO 43017 NDC 7000-0036-1, UPC 0 96295 13807 8", "product_quantity": "5472 bottles", "reason_for_recall": "Presence of Foreign Tablets/Capsules: Complaint involving one Women's Prenatal dietary supplement tablet commingled in a bottle of Extra Strength Acetaminophen 500 mg contents 1000 count bottle.", "recall_initiation_date": "20200203", "center_classification_date": "20200227", "termination_date": "20240422", "report_date": "20200219", "code_info": "Lot #: 193005, Exp. Date 08/21", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0730-2020", "product_description": "FENTANYL 100MCG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12162019@11 Exp. 12/25/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0760-2020", "product_description": "MORPHINE 6MG/ML  INJ in 20 mL syringe Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12162019@19 Exp. 12/25/2019", "more_code_info": ""}, {"country": "United States", "city": "Allegan", "address_1": "515 Eastern Ave", "reason_for_recall": "CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.", "address_2": "", "product_quantity": "", "code_info": "Lots: 8EE1702,   8EE1703,   8EE1704,   8FE1724,   8GE1942,   8HE1396,   8HE1397,   8JE2156,   8KE2521,   8KE2523,   8LE2255,   8LE2665,   8LE2668,   9AE2541,   9AE2542,   9AE2543,   9BE2993,   9BE2994,   9BE2995,   9CE3735,   9CE3736,   9DE3108,   9DE3109,   9DE3110,   9EE2872,   9EE2880,   9FE3273,   9FE3276,   9GE2978,   9GE2979,   9HE3437,   9HE3438", "center_classification_date": "20200313", "distribution_pattern": "Nationwide USA", "state": "MI", "product_description": "Maximum Strength Acid Reducer, Ranitidine tablets, USP 150 mg, 90 tablets per bottle. [Brand, NDC] NDC Equate: 49035-608-75; NDC Up & Up: 11673-023-75", "report_date": "20200325", "classification": "Class II", "openfda": {}, "recalling_firm": "Perrigo Company PLC", "recall_number": "D-1024-2020", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "84127", "termination_date": "20201106", "more_code_info": "", "recall_initiation_date": "20191023", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Torrance", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84550", "recalling_firm": "Asclemed USA Inc. dba Enovachem Pharmaceuticals", "address_1": "379 Van Ness Ave Ste 1403", "address_2": "N/A", "postal_code": "90501-7211", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Product was distributed to 6 physician's offices within the state of California.", "recall_number": "D-0650-2020", "product_description": "Estriol, USP, (Micronized), 0.06 g, Distributed by Enovachem Pharmaceuticals, Torrance CA; NCD #76420-049-36", "product_quantity": "8.52 gm", "reason_for_recall": "Failed Impurities/Degradation Specifications: Additional testing found Out of Specification impurity test results.", "recall_initiation_date": "20191209", "center_classification_date": "20200108", "termination_date": "20230809", "report_date": "20200115", "code_info": "Lot Code/Exp. Date: 11061901, 04011903, 04221904, 04241904,  06031902,  07301905, 09061903, EXP 12/31/2020"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0776-2020", "product_description": "TRIMIX FORTE 30MG/2MG/20MCG/ML INJ in 1 mL vial  Assurance Infusion (713) 533-8800", "product_quantity": "358 vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lots: 08082019@7 Exp. 02/04/2020; 08232019@1 Exp. 02/19/2020; 07262019@12 Exp. 01/22/2020; 07012019@25 Exp. 12/28/2019; 07102019@14 Exp. 01/06/2020; 09202019@4 Exp. 03/18/2020; 10282019@23 Exp. 04/25/2020; 10092019@7 Exp. 03/04/2020; 08292019@11 Exp. 02/25/2020; 10042019@6 Exp. 04/01/2020; 10162019@20 Exp. 04/13/2020; 11062019@24 Exp. 03/04/2020; 12042019@20 Exp. 01/18/2020; 12102019@11 Exp. 01/24/2020; 12162019@36 Exp. 01/30/2020; 11262019@29 Exp. 01/10/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84527", "recalling_firm": "MPRX, Inc. dba Medical Park Pharmacy", "address_1": "8230 Elmbrook Dr Ste 600b", "address_2": "N/A", "postal_code": "75247-4144", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "TX", "recall_number": "D-0809-2020", "product_description": "Magic Bullet Supplement", "product_quantity": "1 bottles", "reason_for_recall": "Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.", "recall_initiation_date": "20191218", "center_classification_date": "20200129", "termination_date": "20221213", "report_date": "20200205", "code_info": "Lot: 61048:99 Use by: 02/08/2020"}, {"country": "United States", "city": "Miami", "address_1": "7715 NW 64th St", "reason_for_recall": "Microbial Contamination of Non-Sterile Products", "address_2": "", "product_quantity": "5387 6 Fl Oz bottles", "code_info": "Lot: 19F332 Exp. June 2022", "center_classification_date": "20200214", "distribution_pattern": "Distributed Nationwide in the USA", "state": "FL", "product_description": "Rompe Pecho EX Expectorant,  6 FL. Oz (178 mL) bottle, Distributed by: Efficient Laboratories, Inc. Miami, FL 33166. UPC 0 00856 30106 1", "report_date": "20200219", "classification": "Class II", "openfda": {}, "recalling_firm": "Efficient Laboratories, Inc.", "recall_number": "D-0846-2020", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "84864", "termination_date": "20201022", "more_code_info": "", "recall_initiation_date": "20200131", "postal_code": "33166-2719", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0758-2020", "product_description": "MORPHINE 4MG/ML  INJ in 20mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "3 syringes", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lots: 12112019@24 Exp. 12/20/2019; 12122019@1 Exp. 12/21/2019; 12122019@2 Exp. 12/21/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0932-2020", "product_description": "Alprostadil/Papaverine Hydrochloride/Phentolamine Mesylate/Atropine Sulfate Injection, 18 mcg/1.8mg/0.2mg/0.02mg/mL, For Intracavernosal Use, Freeze, 2.5 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0547-2", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 12042019+533247, Exp 1/17/2020"}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0963-2020", "product_description": "Lysine Hydrochloride Injection, LYSINE HCL  100MG/ML  INJECTABLE, For IV, IM Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0342-3", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 10222019+53144, Exp 1/27/2020"}, {"status": "Terminated", "city": "Santa Ana", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84622", "recalling_firm": "McGuff Compounding Pharmacy Services, Inc.", "address_1": "2921 W Macarthur Blvd Ste 142", "address_2": "N/A", "postal_code": "92704-7944", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Prescriptions filled for patients in the following states: AK, AZ, CA, CO, DC, FL, IN, MA, MT, NC, NJ, NY, OR, SC, TX, UT, VA, WA, and WI.", "recall_number": "D-0821-2020", "product_description": "Dimercaptopropanesulfonate Sodium (DMPS), Aqueous injection solution, 50mg/mL 5 mL SDV, Rx only, McGuff Compounding Pharmacy Services, Inc. Santa Ana, CA 92704", "product_quantity": "N/A", "reason_for_recall": "Presence of Particulate Matter: Particulates observed in vials release for dispensing.", "recall_initiation_date": "20190214", "center_classification_date": "20200129", "termination_date": "20231120", "report_date": "20200205", "code_info": "Lot #18J1081, Exp 03/10/19"}, {"country": "United States", "city": "Allegan", "address_1": "515 Eastern Ave", "reason_for_recall": "CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.", "address_2": "", "product_quantity": "", "code_info": "Lots: 9BE3161,   9CE3880,   9EE2500,   9FE2823,   9GE2656,   9HE3554,   9JE2676", "center_classification_date": "20200313", "distribution_pattern": "Nationwide USA", "state": "MI", "product_description": "Maximum Strength Acid Reducer, Cool Mint Ranitidine tablets, USP 150 mg, 40 tablets per bottle. [Brand, NDC] NDC Up & Up: 11673-950-58", "report_date": "20200325", "classification": "Class II", "openfda": {}, "recalling_firm": "Perrigo Company PLC", "recall_number": "D-1020-2020", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "84127", "termination_date": "20201106", "more_code_info": "", "recall_initiation_date": "20191023", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0941-2020", "product_description": "B-COMPLEX 110  INJECTABLE, For IV, IM, SC Use, Refrigerate, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0212-3", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 07022019+52584, 07022019+52579, Exp 3/29/2020; 08012019+52780, 08012019+52782, Exp 4/28/2020; 11262019+53288, Exp 8/23/2020"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0712-2020", "product_description": "BUP 5MG/ HYDROM 15MG/ SUF 600MCG/ML (40ML)  INJ in 20 mL syringe Assurance Infusion (713) 533-8800", "product_quantity": "2 syringes", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lots: 12102019@6 Exp. 12/19/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Livonia", "state": "MI", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA204203"], "brand_name": ["QUETIAPINE FUMARATE"], "generic_name": ["QUETIAPINE FUMARATE"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-6801", "0904-6802", "0904-6803", "0904-6804", "0904-6805"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["QUETIAPINE FUMARATE"], "spl_id": ["cdab9d60-c12c-474b-aa71-b7916dab8e7c"], "spl_set_id": ["b02324b1-e7f0-4cbc-8778-5f7c4a5d194a"], "package_ndc": ["0904-6801-61", "0904-6802-61", "0904-6803-61", "0904-6804-61", "0904-6805-61"], "original_packager_product_ndc": ["68180-612", "68180-613", "68180-614", "68180-615", "68180-616"], "unii": ["2S3PL1B6UJ"]}, "product_type": "Drugs", "event_id": "85138", "recalling_firm": "The Harvard Drug Group", "address_1": "17177 N Laurel Park Dr Ste 233", "address_2": "", "postal_code": "48152-3951", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1002-2020", "product_description": "Quetiapine Fumarate Extended-Release Tablets, 300 mg, 100 tablets per unit dose carton, Rx only, Manufactured by: Lupin Limited, Pithampur (M.P.) 454775 India; Distributed by: Major Pharmaceuticals, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI 48152 USA.  NDC: 0904-6804-61", "product_quantity": "", "reason_for_recall": "Labeling; Incorrect or Missing Package Insert: Product was packaged with the package insert for Quetiapine Fumarate Tablets not Quetiapine Fumarate Extended-Release Tablets.", "recall_initiation_date": "20200227", "center_classification_date": "20200311", "termination_date": "20220924", "report_date": "20200318", "code_info": "Lot, expiry: Lot N00037, exp 05/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0976-2020", "product_description": "Mitomycin-C (PF) Irrigation Solution, MITOMYCIN-C (PF) 0.5 MG/ML PF SYRINGE, For Intravesicular Use, Freeze, Cytoxic Agent, Preservative Free, Protect From Light, 80 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0812-8", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 07082019+52606, Exp 4/3/2020; 07242019+52742, Exp 7/22/2020; 07242019+52745, Exp 7/22/2020; 09112019+52907, Exp 5/31/2020; 11142019+53235, Exp 11/12/2020"}, {"status": "Terminated", "city": "Lumberton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84583", "recalling_firm": "AAA Pharmaceutical, Inc.", "address_1": "681 Main St", "address_2": "N/A", "postal_code": "08048-5013", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to one consignee who may have distributed the product further to their retail stores.", "recall_number": "D-0645-2020", "product_description": "Ranitidine 150 mg tablets, 24 count bottles, NDC 37808-196-01.", "product_quantity": "34,272 (24-count bottles)", "reason_for_recall": "CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API", "recall_initiation_date": "20191226", "center_classification_date": "20200106", "termination_date": "20210310", "report_date": "20200115", "code_info": "P134458, Sept 2020  P134943, Aug 2020  P135840, Aug, 2020  P136622, April 2021  P136871, April 2021  P137347, April 2021  P137424, April 2021"}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84208", "recalling_firm": "American Health Packaging", "address_1": "2550 John Glenn Ave Ste A", "address_2": "N/A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0631-2020", "product_description": "Ranitidine Syrup (Ranitidine Oral Solution USP), 15 mg/mL, 150 mg/10 mL per cup, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio.  (a) Case of 50 cups (NDC 60687-260-69) (b) Case of 40 cups (NDC 60687-260-23 (c) Unit Dose Cup (NDC 60687-260-69)", "product_quantity": "1,692 cases of 40 and 50 cups", "reason_for_recall": "CGMP Deviations: Presence of NDMA impurity detected in product.", "recall_initiation_date": "20191101", "center_classification_date": "20191229", "termination_date": "20220803", "report_date": "20200108", "code_info": "[Case of 40] Lots 183723, 184278, exp 10/31/2020; Lot 187652, exp 05/31/2021; [Case of 50] Lot 177874, exp 01/31/ 2020; Lot 178413, exp 02/29/ 2020; Lot 183449, exp 10/31/2020; Lot 184445, exp 12/31/ 2020; Lot 186563, exp 03/31/ 2021; Lot 187691, exp 05/31/2021"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0735-2020", "product_description": "HCG  10,000U/1ML  INJ in 4 mL vial Assurance Infusion (713) 533-8800", "product_quantity": "2 vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lots: 12162019@38 Exp. 01/16/2020; 11272019@32 Exp. 12/31/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0726-2020", "product_description": "FENT 600MCG/ SUF 800MCG/ML INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12162019@8 Exp. 12/25/2019", "more_code_info": ""}, {"country": "United States", "city": "Allegan", "address_1": "515 Eastern Ave", "reason_for_recall": "CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.", "address_2": "", "product_quantity": "", "code_info": "Lots: 8AE1291,   8AE1785,   8BE1415,   8CE1525,   8DE1201,   8DE1741,   8EE1323,   8FE1806,   8GE1965,   8HE1517,   8JE2161,   8KE2565,   8LE2261,   8ME2548,   9AE2658,   9BE3018,   9CE3861,   9DE3244,   9FE2820,   9FE3373,   9GE3094,   9HE3449,   9JE2665", "center_classification_date": "20200313", "distribution_pattern": "Nationwide USA", "state": "MI", "product_description": "Maximum Strength Acid Reducer, Ranitidine tablets, USP 150 mg, 200 tablets per bottle.  [Brand, NDC] NDC Basic Care: 0113-7852-82; NDC CVS Health: 59779-540-82; NDC HEB: 37808-507-82; NDC Signature Care: 21130-116-82; NDC Walgreens: 0363-0852-82", "report_date": "20200325", "classification": "Class II", "openfda": {}, "recalling_firm": "Perrigo Company PLC", "recall_number": "D-1028-2020", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "84127", "termination_date": "20201106", "more_code_info": "", "recall_initiation_date": "20191023", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "84526", "recalling_firm": "Motto International Corp", "address_1": "1908 Royal Ln Ste 700", "address_2": "", "postal_code": "75229-0269", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "TX", "recall_number": "D-0656-2020", "product_description": "Rhino 7 Platinum 30000 Capsules, in blue,orange,black background with red,white,blue,gray text in hologram paper packaging, packaged in 2, 4, and 10 count blister cards, Motto International, Dallas, TX", "product_quantity": "5 boxes", "reason_for_recall": "Marketed without an Approved NDA/ANDA; FDA analysis found product to contain tadalfil", "recall_initiation_date": "20191217", "center_classification_date": "20200110", "termination_date": "20211029", "report_date": "20200122", "code_info": "All lots remaining within expiry.", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0755-2020", "product_description": "MORPHINE 20MG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "3 syringes", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12102019@7 Exp. 12/19/2019; 12112019@11 Exp. 12/20/2019; 12162019@5 Exp. 12/25/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Greenville", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85125", "recalling_firm": "Mayne Pharma Inc", "address_1": "1240 Sugg Pkwy", "address_2": "", "postal_code": "27834-9006", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0998-2020", "product_description": "Carbidopa and Levodopa Tablets, USP 25 mg/250mg, 100 ct bottle, Rx Only, Mayne Pharma, Greenville, NC 27834. NDC 51862-858-01", "product_quantity": "8274 100-count bottles", "reason_for_recall": "Product Mix-Up: A foreign tablet was found in bottle.", "recall_initiation_date": "20200302", "center_classification_date": "20200309", "termination_date": "20211028", "report_date": "20200318", "code_info": "Lot: FG11514 Exp. 05/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Camarillo", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA075977"], "brand_name": ["TRAMADOL HYDROCHLORIDE"], "generic_name": ["TRAMADOL HYDROCHLORIDE"], "manufacturer_name": ["Golden State Medical Supply, Inc."], "product_ndc": ["60429-588"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TRAMADOL HYDROCHLORIDE"], "rxcui": ["835603"], "spl_id": ["3ab10e48-94e2-88fc-e063-6394a90a3efa"], "spl_set_id": ["41d1db45-4d05-49cb-8de5-9444dcf08a6f"], "package_ndc": ["60429-588-01", "60429-588-05"], "original_packager_product_ndc": ["0093-0058"], "unii": ["9N7R477WCK"]}, "product_type": "Drugs", "event_id": "85008", "recalling_firm": "Golden State Medical Supply Inc.", "address_1": "5187 Camino Ruiz", "address_2": "N/A", "postal_code": "93012-8601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0856-2020", "product_description": "TRAMADOL HYDROCHLORIDE Tablets, USP, 50 mg, Rx Only a)100-count bottles (NDC 60429-588-01) b) 500-count bottle (NDC 60429-588-05) Manufactured by Teva Czech Industries, s.r.o. Opava-Komarov, Czech Republic, Packaged by GSMS Incorporated, Camarillo, CA 93012", "product_quantity": "379,043 100-ct bottles and 330,997 500-ct bottles", "reason_for_recall": "Labeling: Incorrect package insert - Patient leaflets for the specified lots of unscored tablets contain language relative to a 25 mg dosing titration that necessitates the use of a scored 50 mg tablet.", "recall_initiation_date": "20200212", "center_classification_date": "20200226", "termination_date": "20230404", "report_date": "20200304", "code_info": "Lot Numbers:   a) GS021259, Exp. Date 11/31/2019; GS021742, GS022074, Exp. 2/29/2020; GS022619, GS022836, 3/31/2020; GS023243, GS023631, Exp. 4/30/2020; GS023869, GS024562, GS025492, Exp. 5/31/2020; GS025184, Exp. 6/30/2020; GS026306, Exp. 9/30/2020; GS026654, Exp.=12/31/2020; GS027566, Exp. 2/28/2020; GS028574, Exp. 4/30/2021;    b) GS021570, GS021444, GS021445, GS021443, GS021447, GS021446, 11/31/2019; GS021745, GS021746, GS021744, GS022076, GS022077, GS022078, GS022075, GS021747, GS021748, Exp. 2/29/2020; GS022622, GS022623, GS022624, GS022620, GS022837, GS022838, GS022856, GS022621, Exp. 3/31/2020; GS023029, GS023028, GS023027, Exp.  4/30/2020; GS023958, GS023959, GS023960, GS025045, GS024929,  GS025048,GS025047, GS025588, GS025046, Exp. Date 5/31/2020; GS025260, GS025259, Exp.6/30/2020; GS025717, GS025719, GS025718, Exp. 8/31/2020; GS023607, GS026308, GS026309, Exp. 9/30/2020; GS026912, GS026911, GS026910, Exp. 12/31/2020; GS027678, Exp. 2/28/2021; GS027836, Exp. 11/30/2020; GS027570, GS027569, Exp. 2/28/2020; GS027572, GS027571, Exp.  4/30/2021"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA075977"], "brand_name": ["TRAMADOL HYDROCHLORIDE"], "generic_name": ["TRAMADOL HYDROCHLORIDE"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0093-0058"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TRAMADOL HYDROCHLORIDE"], "rxcui": ["835603"], "spl_id": ["406611bf-17cb-4c5c-8921-1f3203b79d81"], "spl_set_id": ["6d3b4049-2bfd-4874-b984-8fb231bff27c"], "package_ndc": ["0093-0058-01", "0093-0058-05"], "is_original_packager": [true], "upc": ["0300930058011"], "unii": ["9N7R477WCK"]}, "product_type": "Drugs", "event_id": "84816", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0851-2020", "product_description": "Tramadol Hydrochloride Tablets USP CIV, 50 mg, packaged in a) 100-count bottles (NDC 0093-0058-01), b) 500-count bottles  (NDC 0093-0058-05), RX only, Manufactured in Czech Republic for: Teva Pharmaceuticals USA, Inc., North Wales, PA 19545", "product_quantity": "2,044,497 bottles", "reason_for_recall": "Labeling: Incorrect package insert - Patient leaflets for the specified lots of unscored tablets contain language relative to a 25 mg dosing titration that necessitates the use of a scored 50 mg tablet.", "recall_initiation_date": "20200128", "center_classification_date": "20200219", "termination_date": "20210519", "report_date": "20200226", "code_info": "Lot#: a) 100005876, Exp 02/2020; 100008310, 100008311, Exp 07/2020; 100008638, 100008639, Exp 09/2020; 100011763, 02/2021; b) 100005418, 100005419, 100005420, 100005421, 100005877, 100005878, Exp 01/2020;  100005879, 100005880, 100005881, 100005882, 100005883, 100005884,  100005885, 100005886, 100005887, 100005888, 100005889, 100005890,  100005891, 100005892, 100005893, 100005894, 100005895, 100005896,  100005897, 100005898, 100005899, 100005900, 100005901, 100005902,  100005903, 100006588, 100006718, 100006719, 100006720, 100006721, Exp 02/2020; 100006722,100006724, 100006725, 100006726, 100006727, 100006728, 100006729, 100006730, 100006731, 100006732, 100006733,  100006734, 100006735, 100006736, 100006737, 100006738,100007005,  100007006, 100007007, 100007008, 100007009, 100007010, Exp 03/2020; 100007011, 100007012, 100007013, 100007014, 100007015, 100007016,  100007017, 100007018, 100007019, 100007020, 100007021, 100007022,  100007023, 100007024, 100007025, 100007026, 100007027, 100007028,  100007029, 100007030, 100007031, 100007032, Exp 04/2020; 100007519,  100007520, 100007521, 100007522, 100007523, 100007524, 100007526,  100007527, 100007528, 100007529, 100007530, 100007531, 100007532,  100007533, 100007534, 100007535, 100007536, 100007537, 100007538,  100007539, 100007540, 100007541, Exp 05/2020; 100007849, 100007850,  100007852, 100007853, 100007855, 100007856, 100007858, 100007859,  100007860, 100007861, 100007862, 100007863, Exp 06/2020; 100008296,  100008297, 100008298, 100008299, 100008300, 100008302, 100008303, Exp 07/2020; 100008640, 100008641, 100008643, 100008644, 100008645, 100008646, 100008647, 100008648, 100008649, 100008653, 100008654,  100008655, 100008656, 100008657, 100008658, 100008659, 100008660,  100008661, 100008662, 100008663, 100008664, 100008665, 100008666,  100008667, Exp 08/2020; 100008668, 100008669, 100008670, 100008671,  100009232, 100009233, Exp 09/2020; 100009999, 100010000, 100010001,  100010002, 100010003, 100010004, 100010005, 100010006, 100010007,  100010671, 100010672, 100010673, 100010674, 100010675, 100010676, Exp 12/2020; 100010677, Exp 01/2021; 100010805, 100010806, 100010807,  100010808, 100010809, 100010810, 100010811, 100011709, 100011710,   100011711, 100011712, 100011713, 100011714, 100011715, 100011716,  100011896, Exp 02/2021; 100011897, 100011898, 100011899, 100011900,  100011901, Exp 03/2021; 100011902, 100011903, 100011904, 100011905,  100011906, 100011907, 100011908, 100011909, 100011910, 100011911,  100011912, 100011913, 100011914, 100011918, Exp 04/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0720-2020", "product_description": "CJC-1295 2000 mcg/Ipamorelin 2000 mcg/mL Inj. in 2 mL vial  Assurance Infusion (713) 533-8800", "product_quantity": "19 vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lots: 08212019@29 Exp. 02/17/2020; 07152019@12 Exp. 01/11/2020; 07082019@26 Exp. 01/04/2020;", "more_code_info": ""}, {"country": "United States", "city": "Allegan", "address_1": "515 Eastern Ave", "reason_for_recall": "CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.", "address_2": "", "product_quantity": "", "code_info": "Lots:  8FV1462,   8GV1289,   8BE1465,   8CE1616,   8DE1277,   8DE1580,   8DE1766,   8FE1348,   8GE1527,   8GE1733,   8GE1735,   8HE1466,   8HE1590,   8JE2232,   8KE2676,   8LE2283,   8LE2284,   8LE2345,   8ME2640,   9AE2663,   9AE2863,   9AE2864,   9BE3158,   9CE3773,   9CE3774,   9CE3879,   9EE2499,   9EE2635,   9EE2904,   9FE2821,   9FE2953,   9FE3369,   9GE2653,   9GE2905,   9GE3077,   9GE3115,   9HE3546,   9HE3559,   9JE2593", "center_classification_date": "20200313", "distribution_pattern": "Nationwide USA", "state": "MI", "product_description": "Maximum Strength Acid Reducer, Cool Mint Ranitidine tablets, USP 150 mg, 24 tablets per bottle. [Brand, NDC] NDC Care One: 41520-609-62; NDC CVS Health: 59779-950-62; NDC DG Health: 55910-423-62; NDC Equaline: 41163-950-62; NDC Family Wellness: 55319-523-62; NDC Good Neighbor Pharmacy: 46122-041-62; NDC HEB:  37808-710-02; NDC Kroger: 30142-891-02; NDC Leader: 70000-0378-1; NDC Meijer: 41250-950-02; NDC Rite Aid: 11822-0950-0; NDC Shopko: 37012-950-62; NDC Signature Care: 21130-568-62; NDC Topcare: 36800-950-62; NDC Walgreens: 0363-0950-02", "report_date": "20200325", "classification": "Class II", "openfda": {}, "recalling_firm": "Perrigo Company PLC", "recall_number": "D-1019-2020", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "84127", "termination_date": "20201106", "more_code_info": "", "recall_initiation_date": "20191023", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0672-2020", "product_description": "BAC 4000MCG /FENT 600MCG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12162019@16 Exp. 12/25/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0984-2020", "product_description": "Testosterone Cypionate Injection, TESTOSTERONE CYP IN GRAPESEED OIL [1ML] 200 MG/ML INJECTABLE, For IM Use, 1 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0530-2", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 03062019+51706, Exp 6/28/2020"}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0983-2020", "product_description": "Testosterone Cypionate Injection,TESTOSTERONE CYP IN GRAPESEED OIL [10ML] 200 MG/ML INJECTABLE, For IM Use, 10 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0530-1", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 03252019+51850, Exp 7/6/2020; 04252019+52098, Exp 6/29/2020; 04292019+52108, Exp 6/29/2020; 05012019+52132, Exp 10/22/2020; 05202019+52268, Exp 11/10/2020; 05222019+52290, Exp 11/10/2020; 05302019+52334, Exp 11/20/2020; 07082019+52594, Exp 12/29/2020; 07102019+52619, Exp 12/29/2020; 07292019+52762, Exp 8/12/2020; 07312019+52778, Exp 8/12/2020; 09102019+52898, Exp 1/16/2021; 09112019+52905, Exp 1/18/2021"}, {"status": "Terminated", "city": "Plainsboro", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA203582"], "brand_name": ["MONTELUKAST SODIUM"], "generic_name": ["MONTELUKAST SODIUM"], "manufacturer_name": ["Macleods Pharmaceuticals Limited"], "product_ndc": ["33342-110", "33342-111"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["MONTELUKAST"], "rxcui": ["242438", "311759"], "spl_id": ["a12af8c6-41af-4850-b725-4f8226b35b67"], "spl_set_id": ["ce512844-5220-4661-809f-56d088699c9c"], "package_ndc": ["33342-110-07", "33342-110-10", "33342-110-15", "33342-110-12", "33342-110-39", "33342-110-44", "33342-111-07", "33342-111-10", "33342-111-15", "33342-111-12", "33342-111-39", "33342-111-44"], "is_original_packager": [true], "upc": ["0333342110077", "0333342111074"], "nui": ["N0000175777", "N0000000083"], "pharm_class_epc": ["Leukotriene Receptor Antagonist [EPC]"], "pharm_class_moa": ["Leukotriene Receptor Antagonists [MoA]"], "unii": ["MHM278SD3E"]}, "product_type": "Drugs", "event_id": "84749", "recalling_firm": "Macleods Pharma Usa Inc", "address_1": "666 Plainsboro Rd Bldg 200 Ste 230", "address_2": "N/A", "postal_code": "08536-0009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0823-2020", "product_description": "Montelukast Sodium Chewable Tablets, 5 mg, 90-count bottles, Rx Only, Manufactured for : Macleods Pharma USA, Inc. Plainsboro, NJ Manufactured by: Macleods Pharmaceuticals Ltd Baddi, Himachal Pradesh, India  NDC 33342-111-10", "product_quantity": "10680 units", "reason_for_recall": "Failed Dissolution Specifications:  testing revealed low out of specification result in one lot of product", "recall_initiation_date": "20200120", "center_classification_date": "20200131", "termination_date": "20210426", "report_date": "20200205", "code_info": "Lot #: BMD8901B, Exp. Date 02/2021"}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0950-2020", "product_description": "Deoxycholic Acid Sodium Injection,DEOXYCHOLIC ACID SODIUM 1.67% INJECTABLE, For SC Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0462-3", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 10082019+53080, Exp 6/30/2020; 11192019+53251, Exp  8/24/2020"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0667-2020", "product_description": "BAC 200MCG/ CLONI 250MCG/ MORP 10MG/ML  INJ in 20 mL syringe Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12102019@8 Exp. 12/19/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Bangalore", "state": "", "country": "India", "classification": "Class III", "openfda": {"application_number": ["ANDA210733"], "brand_name": ["POTASSIUM CHLORIDE"], "generic_name": ["POTASSIUM CHLORIDE"], "manufacturer_name": ["Strides Pharma Science Limited"], "product_ndc": ["64380-860", "64380-861"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["POTASSIUM CHLORIDE"], "rxcui": ["312529", "628953"], "spl_id": ["a74390de-64e9-482d-8630-d1a2452324fe"], "spl_set_id": ["0224e5b3-3c49-4e6e-aa78-1abcc6969246"], "package_ndc": ["64380-860-06", "64380-860-07", "64380-860-08", "64380-861-06", "64380-861-07", "64380-861-08"], "is_original_packager": [true], "upc": ["0364380861065", "0364380860068"], "unii": ["660YQ98I10"]}, "product_type": "Drugs", "event_id": "84968", "recalling_firm": "Strides Pharma Science Limited", "address_1": "Krs Gardens, No.36/7 Suragajakkanahalli", "address_2": "Indlawadi Cross, Anekal Taluk", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-1029-2020", "product_description": "Potassium Chloride Extended-Release Tablets USP, 10mEq  (750mg), 1000-count bottle, Rx only, Manufactured by: Strides Shasun Limited Bengaluru - 562106, India, Distributed by: Strides Pharma Inc., East Brunswick, NJ 08816, NDC 64380-861-08", "product_quantity": "2576 bottles", "reason_for_recall": "Failed Tablet/Capsules Specifications: Oversized tablets were found in one lot of Potassium Chloride Tablets 750 mg.", "recall_initiation_date": "20200217", "center_classification_date": "20200313", "termination_date": "20210216", "report_date": "20200325", "code_info": "Lot #: 7238958A, 7238257A, Exp  7/31/2021; 7239404A, Exp 9/30/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Lumberton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "84938", "recalling_firm": "AAA Pharmaceutical, Inc.", "address_1": "681 Main St", "address_2": "N/A", "postal_code": "08048-5013", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Ohio", "recall_number": "D-0868-2020", "product_description": "Discount Drug Mart, Allergy Relief, Fexofenadine Hydrochloride Tablets, 180 mg /Antihistamine, Indoor/Outdoor Allergies, 24 Hour, a) 30 tablets per bottle, NDC 53943-192-04, UPC Code 0-93351-03069-7; b) 45 tablets per bottle, NDC 53943-192-06, UPC Code 0-93351-03070-3, Distributed by: Drug Mart -Food Fair, 211 Commerce Drive, Medina, OH 44256.", "product_quantity": "3456 Bottles", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Expiration date.", "recall_initiation_date": "20200214", "center_classification_date": "20200304", "termination_date": "20230505", "report_date": "20200311", "code_info": "Lot #s: a) P138855, Exp. 05/30/2022; b) P138856, Exp. 05/30/2022"}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0957-2020", "product_description": "Hydroxocobalamin Injection, HYDROXOCOBALAMIN   5MG/ML INJECTABLE, For IV, IM Use, Refrigerate, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0339-3", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 11042019+53179, Exp 2/18/2020"}, {"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021514"], "brand_name": ["DAYTRANA"], "generic_name": ["METHYLPHENIDATE"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-5552", "68968-5553", "68968-5554", "68968-5555"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["METHYLPHENIDATE"], "rxcui": ["753436", "753437", "753438", "753439", "753440", "753441", "753442", "753443"], "spl_id": ["55f4b5f4-6d3c-4677-a94c-d47ffb59a91a"], "spl_set_id": ["2c312c31-3198-4775-91ab-294e0b4b9e7f"], "package_ndc": ["68968-5552-3", "68968-5553-3", "68968-5554-3", "68968-5555-3"], "is_original_packager": [true], "nui": ["N0000175739", "N0000175729"], "pharm_class_epc": ["Central Nervous System Stimulant [EPC]"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "unii": ["207ZZ9QZ49"]}, "product_type": "Drugs", "event_id": "85128", "recalling_firm": "Noven Therapeutics, LLC", "address_1": "11960 Sw 144th St", "address_2": "", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-1045-2020", "product_description": "Daytrana (methylphenidate transdermal system) patches, Delivers 30 mg over 9 hours (3.3 mg/hr), 30-count box, Rx only, Manufactured for Noven Therapeutics, LLC. Miami, FL 33186, NDC 68968-5555-3", "product_quantity": "7469 boxes", "reason_for_recall": "Defective Delivery System: Out of specification for mechanical peel and shear.", "recall_initiation_date": "20200302", "center_classification_date": "20200319", "termination_date": "20230518", "report_date": "20200325", "code_info": "Lot#: 86083, Exp 05/2020; 86282, Exp 06/2020", "more_code_info": ""}, {"country": "United States", "city": "Baltimore", "address_1": "Harborplace Tower", "reason_for_recall": "CGMP Deviations: Out of specification test result observed during retrospective review of blend uniformity test data.", "address_2": "111 S Calvert St Fl 21st", "product_quantity": "34,080 boxes (3 wallets per carton, 80 cartons per box)", "code_info": "Lot # L800498, exp. date February 2020", "center_classification_date": "20200117", "distribution_pattern": "Distributed nationwide in the US", "state": "MD", "product_description": "Tri-Lo-Marzia (Norgestimate and Ethinyl Estradiol Tablets, USP), 0.180 mg/0.025 mg; 0.215mg/0.025 mg and 0.250 mg/0.025 mg, Pack size - 3 x 28's wallets/carton, Rx Only, Distributed by Lupin Pharmaceuticals, Inc, Baltimore MD 21202, Manufactured by: Lupin Limited, Pithampur, (M.P.)- 454775, India. NDC 68180-837-13 (3x28 carton ) NDC 68180-837-11 (28 tablet wallet)", "report_date": "20200122", "classification": "Class III", "openfda": {}, "recalling_firm": "Lupin Pharmaceuticals Inc.", "recall_number": "D-0790-2020", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "84674", "termination_date": "20210603", "more_code_info": "", "recall_initiation_date": "20200110", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Carlstadt", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84827", "recalling_firm": "B AND A TRADING CORPORATION", "address_1": "325 Washington Ave", "address_2": "", "postal_code": "07072-2805", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NY & NJ only", "recall_number": "D-0840-2020", "product_description": "Kushim Tablets (Gushim) 45-count packages, Label in foreign language", "product_quantity": "40 packages", "reason_for_recall": "Marketed Without an Approved NDA/ANDA. FDA analysis found product to contain cinobufagin, bufalin, and bufotenine", "recall_initiation_date": "20200128", "center_classification_date": "20200212", "termination_date": "20231221", "report_date": "20200219", "code_info": "Lot #: H003", "more_code_info": ""}, {"status": "Terminated", "city": "Livonia", "state": "MI", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA204203"], "brand_name": ["QUETIAPINE FUMARATE"], "generic_name": ["QUETIAPINE FUMARATE"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-6801", "0904-6802", "0904-6803", "0904-6804", "0904-6805"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["QUETIAPINE FUMARATE"], "spl_id": ["cdab9d60-c12c-474b-aa71-b7916dab8e7c"], "spl_set_id": ["b02324b1-e7f0-4cbc-8778-5f7c4a5d194a"], "package_ndc": ["0904-6801-61", "0904-6802-61", "0904-6803-61", "0904-6804-61", "0904-6805-61"], "original_packager_product_ndc": ["68180-612", "68180-613", "68180-614", "68180-615", "68180-616"], "unii": ["2S3PL1B6UJ"]}, "product_type": "Drugs", "event_id": "85138", "recalling_firm": "The Harvard Drug Group", "address_1": "17177 N Laurel Park Dr Ste 233", "address_2": "", "postal_code": "48152-3951", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1001-2020", "product_description": "Quetiapine Fumarate Extended-Release Tablets, 200 mg, 100 tablets per unit dose carton, Rx only, Manufactured by: Lupin Limited, Pithampur (M.P.) 454775 India; Distributed by: Major Pharmaceuticals, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI 48152 USA.  NDC: 0904-6803-61", "product_quantity": "115 cartons", "reason_for_recall": "Labeling; Incorrect or Missing Package Insert: Product was packaged with the package insert for Quetiapine Fumarate Tablets not Quetiapine Fumarate Extended-Release Tablets.", "recall_initiation_date": "20200227", "center_classification_date": "20200311", "termination_date": "20220924", "report_date": "20200318", "code_info": "Lot, expiry: Lot N00037, exp 05/2021", "more_code_info": ""}, {"country": "United States", "city": "Miami", "address_1": "7715 NW 64th St", "reason_for_recall": "Microbial Contamination of Non-Sterile Products", "address_2": "", "product_quantity": "5249 6 Fl Oz bottles", "code_info": "Lot: 19H359 Exp. August 2022", "center_classification_date": "20200214", "distribution_pattern": "Distributed Nationwide in the USA", "state": "FL", "product_description": "Rompe Pecho CF Cold & Flu with Honey, 6 FL. Oz (178 mL) bottle, Distributed by: Efficient Laboratories, Inc. Miami, FL 33166.UPC 0 00856 33106 8", "report_date": "20200219", "classification": "Class II", "openfda": {}, "recalling_firm": "Efficient Laboratories, Inc.", "recall_number": "D-0845-2020", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "84864", "termination_date": "20201022", "more_code_info": "", "recall_initiation_date": "20200131", "postal_code": "33166-2719", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0993-2020", "product_description": "Cholecalciferol (Vitamin D3) Injection, VITAMIN D3 [P] 100,000 IU/ML INJECTABLE, For IM Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0251-3", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 04292019+52110, Exp 4/28/2020; 06252019+52525, Exp 6/24/2020; 09252019+52962, 10072019+53051, Exp 8/12/2020"}, {"country": "United States", "city": "Lake Forest", "address_1": "150 N Field Dr Ste 350", "reason_for_recall": "Subpotent Drug", "address_2": "", "product_quantity": "5820 bags", "code_info": "Lot #s:   192930039S Exp. 12/18/19;  192930041S Exp. 12/18/19;  192940048S Exp. 12/19/19;  192940049S Exp. 12/19/19;  192950031S Exp. 12/20/19;  192950032S Exp. 12/20/19;  192960039S Exp. 12/22/19;  192960040S Exp. 12/22/19;  192960041S Exp. 12/22/19;  192960042S Exp. 12/22/19;  192970034S Exp. 12/22/19;  192970036S Exp. 12/22/19;  192970037S Exp. 12/22/19;  192980043S Exp. 12/25/19;  192980044S Exp. 12/25/19;  192980045S Exp. 12/25/19;  193010042S Exp. 12/26/19;  193020042S Exp. 12/27/19;  193030039S Exp. 12/28/19;  193030040S Exp. 12/28/19;  193030049S Exp. 12/28/19;  193040045S Exp. 12/29/19;  193040046S Exp. 12/29/19;  193040047S Exp. 12/29/19;  193080040S Exp. 1/2/20;  193080041S Exp. 1/2/20;  193080042S Exp. 1/2/20;  193080043S Exp. 1/2/20;  193080044S Exp. 1/2/20;  193090034S Exp. 1/3/20;  193090035S Exp. 1/3/20;  193090036S Exp. 1/3/20;  193100041S Exp. 1/4/20;  193100042S Exp. 1/4/20;  193100043S Exp. 1/4/20;  193120036S Exp. 1/8/20;  193150028S Exp. 1/9/20;  193170033S Exp. 1/11/20;  193170034S Exp. 1/11/20;  193170035S Exp. 1/11/20;  193180035S Exp. 1/12/20;  193190035S Exp. 1/15/20;  193190038S Exp. 1/15/20;  193220038S Exp. 1/16/20;  193230037S Exp. 1/17/20;  193240029S Exp. 1/18/20;  193240030S Exp. 1/18/20;  193240031S Exp. 1/18/20;  193250028S Exp. 1/19/20;  193360031S Exp. 1/30/20", "center_classification_date": "20191223", "distribution_pattern": "Nationwide in the U.S.", "state": "IL", "product_description": "NORepinephrine Bitartrate 8 mg added to 250 mL 5% Dextrose Injection USP (32 mcg per mL) Total Volume 258.00 mL Viaflex Bag, High Alert, Rx Only, PharMEDium Services LLC., 12620 W Airport Blvd #130 Sugar Land, TX 77478.", "report_date": "20200101", "classification": "Class III", "openfda": {}, "recalling_firm": "Pharmedium Services, LLC", "recall_number": "D-0625-2020", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "84525", "termination_date": "20210209", "more_code_info": "", "recall_initiation_date": "20191216", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021514"], "brand_name": ["DAYTRANA"], "generic_name": ["METHYLPHENIDATE"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-5552", "68968-5553", "68968-5554", "68968-5555"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["METHYLPHENIDATE"], "rxcui": ["753436", "753437", "753438", "753439", "753440", "753441", "753442", "753443"], "spl_id": ["55f4b5f4-6d3c-4677-a94c-d47ffb59a91a"], "spl_set_id": ["2c312c31-3198-4775-91ab-294e0b4b9e7f"], "package_ndc": ["68968-5552-3", "68968-5553-3", "68968-5554-3", "68968-5555-3"], "is_original_packager": [true], "nui": ["N0000175739", "N0000175729"], "pharm_class_epc": ["Central Nervous System Stimulant [EPC]"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "unii": ["207ZZ9QZ49"]}, "product_type": "Drugs", "event_id": "85128", "recalling_firm": "Noven Therapeutics, LLC", "address_1": "11960 Sw 144th St", "address_2": "", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-1042-2020", "product_description": "Daytrana (methylphenidate transdermal system) patches, Delivers 10 mg over 9 hours (1.1 mg/hr), 30-count box, Rx only, Manufactured for Noven Therapeutics, LLC. Miami, FL 33186,  NDC 68968-5552-3", "product_quantity": "9513 boxes", "reason_for_recall": "Defective Delivery System: Out of specification for mechanical peel and shear.", "recall_initiation_date": "20200302", "center_classification_date": "20200319", "termination_date": "20230518", "report_date": "20200325", "code_info": "Lot#: 86280, Exp 06/2020", "more_code_info": ""}, {"country": "United States", "city": "Baltimore", "address_1": "Harborplace Tower", "reason_for_recall": "Failed Impurities/Degradation Specification; high out of specification results observed", "address_2": "111 S Calvert St Fl 21st", "product_quantity": "876 bottles", "code_info": "K800475 exp. date May 2020  K800477 exp. date June 2020", "center_classification_date": "20200303", "distribution_pattern": "Product was distributed throughout the United States.", "state": "MD", "product_description": "Desoximetasone Topical Spray, 0.25%, 2.5 mg desoximetasone, 100 mL bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Baltimore, MD", "report_date": "20200311", "classification": "Class II", "openfda": {}, "recalling_firm": "Lupin Pharmaceuticals Inc.", "recall_number": "D-0866-2020", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "85015", "termination_date": "20210603", "recall_initiation_date": "20200219", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA210244"], "brand_name": ["GLYCOPYRROLATE"], "generic_name": ["GLYCOPYRROLATE"], "manufacturer_name": ["AuroMedics Pharma LLC"], "product_ndc": ["55150-292", "55150-293", "55150-294", "55150-295"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["GLYCOPYRROLATE"], "rxcui": ["238212", "1731582", "1731590"], "spl_id": ["eea49fec-ee88-4ac2-bc4f-5ff7a7b1bbda"], "spl_set_id": ["eaebb511-1738-4d11-b9bb-317a8d41316a"], "package_ndc": ["55150-292-01", "55150-293-02", "55150-294-05", "55150-295-20"], "is_original_packager": [true], "upc": ["0355150295203"], "unii": ["V92SO9WP2I"]}, "product_type": "Drugs", "event_id": "84927", "recalling_firm": "AuroMedics Pharma LLC", "address_1": "279 Princeton Hightstown Rd", "address_2": "", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Ohio, Louisiana, Mississippi", "recall_number": "D-0853-2020", "product_description": "Glycopyrrolate Injection, USP 4 mg per 20 mL (0.2 mg/mL), 20 mL Multiple Dose Vial, Rx Only, For Intramuscular or Intravenous Use, Not for Use in Newborns, Contains Benzyl Alcohol, Distributed by: AuroMedics Pharma LLC, 279 Princeton-Hightstown Rd., E. Windsor, NJ, 08520, Made in India, NDC 55150-295-20.", "product_quantity": "4600 Vials", "reason_for_recall": "Failed Impurities/Degradation Specifications: elevated levels of Benzaldehyde impurity was found in investigative samples (retain samples).", "recall_initiation_date": "20200207", "center_classification_date": "20200220", "termination_date": "20230308", "report_date": "20200226", "code_info": "Lot #CGP190001-A, Exp. 07/31/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Cranbury", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA065053"], "brand_name": ["DOXYCYCLINE"], "generic_name": ["DOXYCYCLINE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["63304-614", "63304-615", "63304-616"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DOXYCYCLINE"], "rxcui": ["700408", "1649401", "1649990"], "spl_id": ["338488d1-e9d8-6b00-e063-6294a90a37c0"], "spl_set_id": ["829dbd3d-5c2b-47b8-96a5-423af78c93b9"], "package_ndc": ["63304-614-20", "63304-614-05", "63304-614-01", "63304-614-13", "63304-615-05", "63304-615-11", "63304-615-01", "63304-616-20", "63304-616-05", "63304-616-01", "63304-616-13", "63304-616-50"], "is_original_packager": [true], "upc": ["0363304614015"], "nui": ["N0000175882", "N0000007948"], "pharm_class_epc": ["Tetracycline-class Drug [EPC]"], "pharm_class_cs": ["Tetracyclines [Chemical/Ingredient]"], "unii": ["N12000U13O"]}, "product_type": "Drugs", "event_id": "85230", "recalling_firm": "Sun Pharmaceutical Industries, Inc.", "address_1": "270 Prospect Plains Rd", "address_2": "", "postal_code": "08512-3605", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1033-2020", "product_description": "Doxycycline Capsules, USP, 100 mg, 50-count bottle, Rx only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901; Distributed by Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; NDC 63304-616-50.", "product_quantity": "172,320 bottles", "reason_for_recall": "CGMP Deviations: Doxycycline capsules were not manufactured under Current Good Manufacturing Practice conditions.", "recall_initiation_date": "20200313", "center_classification_date": "20200318", "termination_date": "20210209", "report_date": "20200325", "code_info": "Lot #: 3983720, Exp 10/2020; 3990461, 3990464, 3990465, 3990466, 3990470, Exp 11/2020; AA42499, AA42510, AA44468, AA44470, Exp 04/2021; AA55073, AA55074, AA55075, Exp 05/2021; AA61486, Exp 06/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0969-2020", "product_description": "Methylprednisolone Acetate/Bupivacaine Hydrochloride Injectable Suspension, METHYLPRED ACETATE/BUPIVACAINE HCL [10ML] CMC 80MG/5MG/ML INJ SUSP, For IM, IA Use, Shake Well, 10 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0624-1", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 09042019+52876, Exp 3/2/2020"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0674-2020", "product_description": "BAC 50MCG/ HYDROM 10MG/ML   INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12112019@27 Exp. 12/20/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0718-2020", "product_description": "BUP 8MG/CLON 100MCG/HYDROM 20MG/ML  INJ in 20 mL syringe Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lots: 12122019@5 Exp. 12/21/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0664-2020", "product_description": "BAC 150 mcg/BUP 2 mg/Hydrom 15 mg/Morp 20 mg/SUF 650 mcg/mL Inj. in 20 mL syringe Assurance Infusion (713)533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12172019@2 Exp. 12/26/2019", "more_code_info": ""}]